Department of Emergency Medicine, Ajou University School of Medicine, Suwon, Korea.
J Korean Med Sci. 2023 Jan 16;38(3):e18. doi: 10.3346/jkms.2023.38.e18.
The coronavirus disease 2019 (COVID-19) omicron (B.1.1.529) variant reduced the risk of severe disease compared with the original strain and other variants, but it appeared to be highly infectious, which resulted in an exponential increase in confirmed cases in South Korea. As the number of confirmed cases increased, so did the number of pediatric patients' hospitalization. This study aims to evaluate the frequency and clinical features of febrile seizure associated with the COVID-19 omicron variant in children.
We retrospectively reviewed the medical records of children aged under 18 years with febrile seizure who were tested for COVID-19 from February 2020 to April 2022 at Ajou University Hospital, South Korea. Based on the dominant variants, we divided the period into the pre-omicron (from February 2020 to December 2021) and omicron periods (from January 2022 to April 2022) and compared the clinical characteristics between the two. Also, we compared the clinical characteristics of febrile seizure between COVID-19 positive and negative group during the omicron period.
Among the 308 children, 211 patients (9.2 patients/months) and 97 patients (24.3 patients/months) were grouped into pre-omicron and omicron periods, respectively. Compared with the pre-omicron period, patients in the omicron period showed significantly higher mean age (pre-omicron vs. omicron, 22.0 vs. 28.0 months; = 0.004) and COVID-19 positive results (pre-omicron vs. omicron, 0.5% vs. 62.9%; < 0.001). As the COVID-19 confirmed cases in the omicron period increased, the number of COVID-19 associated febrile seizure also increased. In the omicron period, 61 children were confirmed to be positive for COVID-19, and COVID-19 positive group showed statistically significant higher mean age (positive vs. negative, 33.0 vs. 23.0 months; = 0.003) and peak body temperature than the negative group (positive vs. negative, 39.1°C vs. 38.6°C; = 0.030). Despite the lack of significance, COVID-19 positive group showed longer seizure time, multiple seizure episodes, and higher prevalence of complex febrile seizure.
The frequency of COVID-19 associated febrile seizure increased in the omicron periods. In addition, in this period, children with febrile seizure diagnosed with COVID-19 had a higher mean age and higher peak body temperature.
与原始毒株和其他变异株相比,新型冠状病毒病 2019(COVID-19)奥密克戎(B.1.1.529)变异株降低了患重病的风险,但它似乎具有高度传染性,这导致韩国确诊病例呈指数级增长。随着确诊病例数量的增加,儿科患者住院人数也随之增加。本研究旨在评估与 COVID-19 奥密克戎变异株相关的儿童热性惊厥的频率和临床特征。
我们回顾性分析了 2020 年 2 月至 2022 年 4 月在韩国 Ajou 大学医院就诊的年龄在 18 岁以下、伴有热性惊厥的 COVID-19 检测阳性患儿的病历。根据主要变异株,我们将该时期分为前奥密克戎时期(2020 年 2 月至 2021 年 12 月)和奥密克戎时期(2022 年 1 月至 2022 年 4 月),并比较了两个时期的临床特征。此外,我们比较了奥密克戎时期 COVID-19 阳性组和阴性组热性惊厥的临床特征。
在 308 名患儿中,211 名患儿(9.2 例/月)和 97 名患儿(24.3 例/月)分别被分为前奥密克戎组和奥密克戎组。与前奥密克戎时期相比,奥密克戎时期患儿的平均年龄明显较高(前奥密克戎 vs. 奥密克戎,22.0 个月 vs. 28.0 个月; = 0.004),COVID-19 阳性率也明显较高(前奥密克戎 vs. 奥密克戎,0.5% vs. 62.9%; < 0.001)。随着奥密克戎时期确诊病例的增加,COVID-19 相关热性惊厥的数量也随之增加。在奥密克戎时期,有 61 名患儿被确诊为 COVID-19 阳性,COVID-19 阳性组的平均年龄(阳性 vs. 阴性,33.0 个月 vs. 23.0 个月; = 0.003)和最高体温均明显高于阴性组(阳性 vs. 阴性,39.1°C vs. 38.6°C; = 0.030)。尽管无统计学意义,但 COVID-19 阳性组的惊厥时间更长,发作次数更多,且复杂性热性惊厥的发生率更高。
奥密克戎时期 COVID-19 相关热性惊厥的发生率增加。此外,在此期间,诊断为 COVID-19 的热性惊厥患儿的平均年龄和最高体温均较高。